Charity Dinner Fondazione Veronesi Como 2026

The annual Charity Dinner organised by the Como delegation of Fondazione Umberto Veronesi is one of the most important institutional events of the year, providing an opportunity to bring together companies and supporters who share and believe in the values that inspire the Foundation.

The funds raised during the evening will support scientific research into childhood cancers and, in particular, will help finance a new clinical trial focusing on high-risk neuroblastoma. Coordinated by the Bambino Gesù Children's Hospital in Rome and conducted in collaboration with several European centres, the trial aims to assess the effectiveness of a new treatment based on CAR-T cells, which are genetically modified to recognise and specifically target cancer cells. Neuroblastoma is the most common extracranial solid tumour in children, accounting for approximately 10% of all childhood cancers. Around half of affected children are diagnosed with a high-risk form of the disease, for which the likelihood of relapse or resistance to treatment remains high. The effectiveness of CAR-T cell therapy has already been investigated in an initial study, which showed promising results in 77% of patients. The new trial aims to confirm these findings and make this innovative treatment available to an increasing number of children.

Much has been achieved, but there is still more to be done. This is why Fondazione Veronesi is committed to supporting scientific research and access to the best possible care for children and young people affected by cancer, helping to improve both their life expectancy and quality of life.